Media coverage about Waters (NYSE:WAT) has trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Waters earned a coverage optimism score of 0.21 on Accern’s scale. Accern also gave news stories about the medical instruments supplier an impact score of 45.9967279476525 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
These are some of the media headlines that may have effected Accern’s analysis:
- How to get over 60% of Capetonians to understand there is a water crisis (capetalk.co.za)
- Oscars 2018 nominations – list in full: The Shape of Water leads pack, followed by Dunkirk and Three Billboards (independent.co.uk)
- What is The Shape of Water about? Sally Hawkins, Octavia Spencer and Michael Shannon star in Oscar nominated movie (metro.co.uk)
- Toledo, Lucas Co., suburbs close to regional water agreement (toledoblade.com)
- The Shape Of Water sweeps the board with 13 Academy Award nominations… while Dunkirk and Three Billboards Outside Ebbing, Missouri emerge as strong Oscars contenders (dailymail.co.uk)
A number of equities research analysts recently weighed in on the stock. Goldman Sachs Group assumed coverage on shares of Waters in a report on Tuesday, September 26th. They issued a “hold” rating and a $180.00 target price on the stock. Barclays upped their target price on shares of Waters from $188.00 to $193.00 and gave the stock an “equal weight” rating in a report on Wednesday, October 25th. Zacks Investment Research upgraded shares of Waters from a “hold” rating to a “buy” rating and set a $211.00 target price on the stock in a report on Monday, October 23rd. Citigroup restated a “neutral” rating and issued a $180.00 target price on shares of Waters in a report on Wednesday, October 25th. Finally, Morgan Stanley restated an “underweight” rating and issued a $192.00 target price (up previously from $183.00) on shares of Waters in a report on Friday, October 6th. Eleven equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $197.33.
Waters (WAT) traded down $3.78 during trading hours on Tuesday, reaching $210.99. 1,038,577 shares of the company’s stock traded hands, compared to its average volume of 532,473. The company has a debt-to-equity ratio of 0.66, a quick ratio of 5.71 and a current ratio of 6.16. The stock has a market cap of $16,780.00, a price-to-earnings ratio of 31.12, a price-to-earnings-growth ratio of 2.82 and a beta of 0.82. Waters has a 52-week low of $137.72 and a 52-week high of $218.72.
Waters (NYSE:WAT) last posted its quarterly earnings data on Tuesday, January 23rd. The medical instruments supplier reported $2.51 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.44 by $0.07. The firm had revenue of $687.28 million during the quarter, compared to analyst estimates of $671.98 million. Waters had a net margin of 24.34% and a return on equity of 23.61%. The company’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same quarter last year, the business posted $2.21 EPS. analysts expect that Waters will post 7.42 earnings per share for the current year.
In other Waters news, SVP Rohit Khanna sold 26,913 shares of the stock in a transaction dated Friday, October 27th. The shares were sold at an average price of $197.93, for a total value of $5,326,890.09. Following the completion of the sale, the senior vice president now owns 13,677 shares in the company, valued at approximately $2,707,088.61. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Joann A. Reed sold 1,386 shares of the stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $194.07, for a total transaction of $268,981.02. The disclosure for this sale can be found here. In the last quarter, insiders sold 93,159 shares of company stock valued at $18,412,172. Company insiders own 5.07% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This article was originally published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.truebluetribune.com/2018/01/23/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-waters-wat-share-price.html.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.